NERM
HOLX

New England Research & Management’s Hologic HOLX Stock Holding History

New England Research & Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,575
Closed -$417K – 158
2022
Q4 		$417K Buy
5,575
+75
+1% +$5.34K 0.24% 119
2022
Q3 		$355K Hold
5,500
– – 0.22% 120
2022
Q2 		$381K Buy
+5,500
New +$408K 0.22% 119

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

New England Research & Management's HOLX Position: Q1 2023 in Review

New England Research & Management sold out of Hologic (HOLX) in Q1 2023, closing a stake of 5,575 shares — an estimated $417K sold.

New England Research & Management first reported a position in HOLX in Q2 2022 and held it in 3 quarters. The position peaked at $417K in Q4 2022. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • New England Research & Management reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • New England Research & Management sold 5,575 Hologic shares in Q1 2023, an estimated $417K.
  • New England Research & Management first reported a position in Hologic in Q2 2022 and held it in 3 quarters.
  • New England Research & Management's Hologic position peaked at $417K in Q4 2022.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on New England Research & Management's 13F filing for Q1 2023, filed 6 Apr 2023.